n-methyl-3,4-methylenedioxyamphetamine has been researched along with Atrophy in 4 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Multiple neurological complications of cocaine abuse have been described including both ischemic and hemorrhagic cerebrovascular events, atrophy in the case of chronic abuse, and an increase in incidence of congenital malformations in the setting of maternal use." | 2.43 | Neuroimaging in drug and substance abuse part I: cocaine, cannabis, and ecstasy. ( Borne, J; Cuellar, H; Riascos, R; Rojas, R; Vargas, D, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ruis, C | 1 |
| Postma, A | 1 |
| Bouvy, W | 1 |
| van der Ham, I | 1 |
| Gardner, H | 1 |
| Lawn, N | 1 |
| Fatovich, DM | 1 |
| Archer, JS | 1 |
| Rojas, R | 1 |
| Riascos, R | 1 |
| Vargas, D | 1 |
| Cuellar, H | 1 |
| Borne, J | 1 |
| Lehmann, J | 1 |
| DeSouza, EB | 1 |
| Culp, S | 1 |
| Zaczek, R | 1 |
1 review available for n-methyl-3,4-methylenedioxyamphetamine and Atrophy
| Article | Year |
|---|---|
Neuroimaging in drug and substance abuse part I: cocaine, cannabis, and ecstasy.
Topics: Atrophy; Central Nervous System Diseases; Cocaine-Related Disorders; Female; Hallucinogens; Humans; | 2005 |
3 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Atrophy
| Article | Year |
|---|---|
Cognitive disorders after sporadic ecstasy use? A case report.
Topics: Adult; Atrophy; Cognition Disorders; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memory; | 2015 |
Acute hippocampal sclerosis following ecstasy ingestion.
Topics: Adrenergic Uptake Inhibitors; Adult; Atrophy; Brain Damage, Chronic; Brain Diseases, Metabolic; Epil | 2009 |
Regional distribution to recovery of 5-HT levels after administration of "atrophins" MDMA and D,L-fenfluramine. Stereospecificity and comparison with 5,7-dihydroxytryptamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; 5,7-Dihydroxytryptamine; Animals; Atr | 1992 |